Expression of Indoleamine 2,3-Dioxygenase In Carcinoma of Human Endometrium And Uterine Cervix
- 13 Citations
- 1.1k Downloads
Abstract
Expression of indoleamine 2,3-dioxygenase (IDO) in epithelium of the endometrium and the cervix is not restricted to normal but also present in carcinomatous tissue. The enzyme was found in the majority of cases studied, pioneer cells at the invasion front of the tumors being especially strongly reactive in immunohistology. In addition, also cells in the peritumoral infiltrate of the stroma expressed IDO. Taken together, these findings together with previous data on the immunosuppressive impact of tryptophan depletion suggest IDO-induced suppression of antitumoral immune response in both adenocarcinoma and squamous cell carcinoma of endometrium and cervix. On the other hand, IDO as also known to inhibit tumor cell proliferation by tryptophan depletion.
Keywords
Invasion Front Human Endometrium Tryptophan Depletion Glandular Epithelial Cell Cervix CarcinomaPreview
Unable to display preview. Download preview PDF.
References
- 1.D.H. Munn, M. Zhou, J.T. Attwood, I. Bondarev, S.J. Conway, B. Marshall, C. Brown and A.L. Mellor. Prevention of allogeneic fetal rejection by tryptophan catabolism, [see comments]. Science. 281, 1191–1193 (1998).PubMedCrossRefGoogle Scholar
- 2.D.H. Munn, E. Shafizadeh, J.T. Attwood, I. Bondarev, A. Pashine and A.L. Mellor, Inhibition of T cell proliferation by macrophage tryptophan catabolism, J. Exp. Med. 189, 1363–1372 (1999).PubMedCrossRefGoogle Scholar
- 3.P. Sedlmayr, A. Blaschitz, R. Wintersteiger, M. Semlitsch, A. Hammer, C.R. MacKenzie, W. Walcher, O. Reich, O. Takikawa and G. Dohr, Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta, Mol. Hum. Reprod. 8, 385–391 (2002).Google Scholar
- 4.O. Takikawa, T. Kuroiwa, F. Yamazaki and R. Kido, Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity, J Biol. Chem.. 263, 2041–2048 (1988).PubMedGoogle Scholar
- 5.Y. Ozaki, M.P. Edelstein and D.S. Duch, Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma, Proc. Nat!. Acad. Sci. USA. 85, 1242–1246 (1988).PubMedCrossRefGoogle Scholar
- 6.Y. Kudo and C.A. Boyd, The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants, J. Physiol. 531, 417–423 (2001).PubMedCrossRefGoogle Scholar
- 7.A.L. Mellor, D.B. Keskin, T. Johnson, P. Chandler and D.H. Munn, Cells expressing indoleamine 2,3dioxygenase inhibit T cell responses, J. Immunol. 168, 3771–3776 (2002).PubMedGoogle Scholar
- 8.G.J. Logan, C.M.F. Smyth, J.W. Earl, I. Zaikina, P.B. Rowe, J.A. Smythe and I.E. Alexander, HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3-dioxygenase activity, Immunology 105, 478–487 (2002).PubMedCrossRefGoogle Scholar
- 9.O. Takikawa, A. Habara Ohkubo and R. Yoshida. IFN-gamma is the inducer of indoleamine 2,3dioxygenase in allografted tumor cells undergoing rejection, J. Immunol. 145, 1246–1250 (1990).PubMedGoogle Scholar
- 10.C. Muff, B. Widner, B. Spemer-Unterweger, M. Ledochowski, C. Schubert and D. Fuchs, Immune reaction links disease progression in cancer patients with depression, Med. Hypotheses. 55, 137–140 (2000).CrossRefGoogle Scholar